Cargando…
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
PURPOSE: To explore the role of NBN as a pan-cancer susceptibility gene. EXPERIMENTAL DESIGN: Matched germline and somatic DNA samples from 34,046 patients were sequenced using Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets and presumed pathogenic germline varian...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843434/ https://www.ncbi.nlm.nih.gov/pubmed/36346689 http://dx.doi.org/10.1158/1078-0432.CCR-22-1703 |
_version_ | 1784870401758724096 |
---|---|
author | Belhadj, Sami Khurram, Aliya Bandlamudi, Chaitanya Palou-Márquez, Guillermo Ravichandran, Vignesh Steinsnyder, Zoe Wildman, Temima Catchings, Amanda Kemel, Yelena Mukherjee, Semanti Fesko, Benjamin Arora, Kanika Mehine, Miika Dandiker, Sita Izhar, Aalin Petrini, John Domchek, Susan Nathanson, Katherine L. Brower, Jamie Couch, Fergus Stadler, Zsofia Robson, Mark Walsh, Michael Vijai, Joseph Berger, Michael Supek, Fran Karam, Rachid Topka, Sabine Offit, Kenneth |
author_facet | Belhadj, Sami Khurram, Aliya Bandlamudi, Chaitanya Palou-Márquez, Guillermo Ravichandran, Vignesh Steinsnyder, Zoe Wildman, Temima Catchings, Amanda Kemel, Yelena Mukherjee, Semanti Fesko, Benjamin Arora, Kanika Mehine, Miika Dandiker, Sita Izhar, Aalin Petrini, John Domchek, Susan Nathanson, Katherine L. Brower, Jamie Couch, Fergus Stadler, Zsofia Robson, Mark Walsh, Michael Vijai, Joseph Berger, Michael Supek, Fran Karam, Rachid Topka, Sabine Offit, Kenneth |
author_sort | Belhadj, Sami |
collection | PubMed |
description | PURPOSE: To explore the role of NBN as a pan-cancer susceptibility gene. EXPERIMENTAL DESIGN: Matched germline and somatic DNA samples from 34,046 patients were sequenced using Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets and presumed pathogenic germline variants (PGV) identified. Allele-specific and gene-centered analysis of enrichment was conducted and a validation cohort of 26,407 pan-cancer patients was analyzed. Functional studies utilized cellular models with analysis of protein expression, MRN complex formation/localization, and viability assessment following treatment with γ-irradiation. RESULTS: We identified 83 carriers of 32 NBN PGVs (0.25% of the studied series), 40% of which (33/83) carried the Slavic founder p.K219fs. The frequency of PGVs varied across cancer types. Patients harboring NBN PGVs demonstrated increased loss of the wild-type allele in their tumors [OR = 2.7; confidence interval (CI): 1.4–5.5; P = 0.0024; pan-cancer], including lung and pancreatic tumors compared with breast and colorectal cancers. p.K219fs was enriched across all tumor types (OR = 2.22; CI: 1.3–3.6; P = 0.0018). Gene-centered analysis revealed enrichment of PGVs in cases compared with controls in the European population (OR = 1.9; CI: 1.3–2.7; P = 0.0004), a finding confirmed in the replication cohort (OR = 1.8; CI: 1.2–2.6; P = 0.003). Two novel truncating variants, p.L19* and p.N71fs, produced a 45 kDa fragment generated by alternative translation initiation that maintained binding to MRE11. Cells expressing these fragments showed higher sensitivity to γ-irradiation and lower levels of radiation-induced KAP1 phosphorylation. CONCLUSIONS: Burden analyses, biallelic inactivation, and functional evidence support the role of NBN as contributing to a broad cancer spectrum. Further studies in large pan-cancer series and the assessment of epistatic and environmental interactions are warranted to further define these associations. |
format | Online Article Text |
id | pubmed-9843434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association for Cancer Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-98434342023-01-19 NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects Belhadj, Sami Khurram, Aliya Bandlamudi, Chaitanya Palou-Márquez, Guillermo Ravichandran, Vignesh Steinsnyder, Zoe Wildman, Temima Catchings, Amanda Kemel, Yelena Mukherjee, Semanti Fesko, Benjamin Arora, Kanika Mehine, Miika Dandiker, Sita Izhar, Aalin Petrini, John Domchek, Susan Nathanson, Katherine L. Brower, Jamie Couch, Fergus Stadler, Zsofia Robson, Mark Walsh, Michael Vijai, Joseph Berger, Michael Supek, Fran Karam, Rachid Topka, Sabine Offit, Kenneth Clin Cancer Res Translational Cancer Mechanisms and Therapy PURPOSE: To explore the role of NBN as a pan-cancer susceptibility gene. EXPERIMENTAL DESIGN: Matched germline and somatic DNA samples from 34,046 patients were sequenced using Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets and presumed pathogenic germline variants (PGV) identified. Allele-specific and gene-centered analysis of enrichment was conducted and a validation cohort of 26,407 pan-cancer patients was analyzed. Functional studies utilized cellular models with analysis of protein expression, MRN complex formation/localization, and viability assessment following treatment with γ-irradiation. RESULTS: We identified 83 carriers of 32 NBN PGVs (0.25% of the studied series), 40% of which (33/83) carried the Slavic founder p.K219fs. The frequency of PGVs varied across cancer types. Patients harboring NBN PGVs demonstrated increased loss of the wild-type allele in their tumors [OR = 2.7; confidence interval (CI): 1.4–5.5; P = 0.0024; pan-cancer], including lung and pancreatic tumors compared with breast and colorectal cancers. p.K219fs was enriched across all tumor types (OR = 2.22; CI: 1.3–3.6; P = 0.0018). Gene-centered analysis revealed enrichment of PGVs in cases compared with controls in the European population (OR = 1.9; CI: 1.3–2.7; P = 0.0004), a finding confirmed in the replication cohort (OR = 1.8; CI: 1.2–2.6; P = 0.003). Two novel truncating variants, p.L19* and p.N71fs, produced a 45 kDa fragment generated by alternative translation initiation that maintained binding to MRE11. Cells expressing these fragments showed higher sensitivity to γ-irradiation and lower levels of radiation-induced KAP1 phosphorylation. CONCLUSIONS: Burden analyses, biallelic inactivation, and functional evidence support the role of NBN as contributing to a broad cancer spectrum. Further studies in large pan-cancer series and the assessment of epistatic and environmental interactions are warranted to further define these associations. American Association for Cancer Research 2023-01-17 2022-11-08 /pmc/articles/PMC9843434/ /pubmed/36346689 http://dx.doi.org/10.1158/1078-0432.CCR-22-1703 Text en ©2022 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. |
spellingShingle | Translational Cancer Mechanisms and Therapy Belhadj, Sami Khurram, Aliya Bandlamudi, Chaitanya Palou-Márquez, Guillermo Ravichandran, Vignesh Steinsnyder, Zoe Wildman, Temima Catchings, Amanda Kemel, Yelena Mukherjee, Semanti Fesko, Benjamin Arora, Kanika Mehine, Miika Dandiker, Sita Izhar, Aalin Petrini, John Domchek, Susan Nathanson, Katherine L. Brower, Jamie Couch, Fergus Stadler, Zsofia Robson, Mark Walsh, Michael Vijai, Joseph Berger, Michael Supek, Fran Karam, Rachid Topka, Sabine Offit, Kenneth NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects |
title |
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects |
title_full |
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects |
title_fullStr |
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects |
title_full_unstemmed |
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects |
title_short |
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects |
title_sort | nbn pathogenic germline variants are associated with pan-cancer susceptibility and in vitro dna damage response defects |
topic | Translational Cancer Mechanisms and Therapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843434/ https://www.ncbi.nlm.nih.gov/pubmed/36346689 http://dx.doi.org/10.1158/1078-0432.CCR-22-1703 |
work_keys_str_mv | AT belhadjsami nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT khurramaliya nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT bandlamudichaitanya nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT paloumarquezguillermo nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT ravichandranvignesh nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT steinsnyderzoe nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT wildmantemima nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT catchingsamanda nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT kemelyelena nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT mukherjeesemanti nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT feskobenjamin nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT arorakanika nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT mehinemiika nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT dandikersita nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT izharaalin nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT petrinijohn nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT domcheksusan nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT nathansonkatherinel nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT browerjamie nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT couchfergus nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT stadlerzsofia nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT robsonmark nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT walshmichael nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT vijaijoseph nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT bergermichael nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT supekfran nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT karamrachid nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT topkasabine nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects AT offitkenneth nbnpathogenicgermlinevariantsareassociatedwithpancancersusceptibilityandinvitrodnadamageresponsedefects |